For the last half century, Traumatic Brain Injury (TBI) cases have been handled by mostly the same method by medical ...

BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotech company ...

An updated framework for addressing traumatic brain injury places the focus on the acute phase, while considering internal, external and modifying factors that influence outcomes from these events, ...

Traumatic brain injury research faces significant funding cuts nationwide – including in Alabama. Rihanna Staged the Most Outrageous Pregnancy Reveal at the 2025 Met Gala Ranking All-You-Can-Eat ...

Innovative developers are refining and validating their offerings to fit particular testing questions, such as drug-induced liver injury (DILI). Although these in vitro models will also not ...

A recent groundbreaking study published in Nature has opened a promising new chapter in the treatment of traumatic brain injury (TBI) and other forms ... shown promise in ameliorating symptoms in ...

A nasal spray developed to combat neuroinflammation has shown promise in treating traumatic brain injury (TBI) in mouse models. The findings were published in Nature Neuroscience and may pave the way ...

That could be a possibility one day after a new study found that a monoclonal antibody-based nasal spray helped to promote recovery from traumatic brain injury ... in mouse models of moderate ...

"It also means this could work in intracerebral hemorrhage and other stroke patients with brain injury." Multiple experiments were done in mouse models with moderate-to-severe traumatic brain ...

A new study led by researchers at Mass General Brigham suggests a nasal spray developed to target neuroinflammation could one day be an effective treatment for traumatic brain injury (TBI). By ...

Infectious or chronic diseases such as long COVID, Alzheimer’s disease and traumatic brain injury can cause inflammation ... in the context of simplified models, we don’t know whether it ...

following a single moderate traumatic brain injury. This second pre-clinical study in a rodent model, supported by the US Department of Defense (DOD), is a collaboration with investigators at the ...